Pathogenic mechanisms of pulmonary arterial hypertension
- 1 January 2008
- journal article
- review article
- Published by Elsevier BV in Journal of Molecular and Cellular Cardiology
- Vol. 44 (1), 14-30
- https://doi.org/10.1016/j.yjmcc.2007.09.006
Abstract
No abstract availableKeywords
This publication has 238 references indexed in Scilit:
- Human disease classification in the postgenomic era: A complex systems approach to human pathobiologyMolecular Systems Biology, 2007
- Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle‐like cells regulated by myocardin involved in hypoxia‐induced pulmonary vascular remodellingInternational Journal of Experimental Pathology, 2006
- Carbon monoxide reverses established pulmonary hypertensionThe Journal of Experimental Medicine, 2006
- Simvastatin enhances bone morphogenetic protein receptor type II expressionBiochemical and Biophysical Research Communications, 2006
- Clinical classification of pulmonary hypertensionJournal of the American College of Cardiology, 2004
- Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted MiceScience, 2001
- Augmented adrenomedullin concentrations in right ventricle and plasma of experimental pulmonary hypertensionLife Sciences, 1995
- The endogenous vascular elastase that governs development and progression of monocrotaline-induced pulmonary hypertension in rats is a novel enzyme related to the serine proteinase adipsin.JCI Insight, 1994
- Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertension.JCI Insight, 1990
- Leukotriene C4and D4in Neonates with Hypoxemia and Pulmonary HypertensionNew England Journal of Medicine, 1983